rapivab - peramivir solution
(Peramivir)Biocryst Pharmaceuticals, Inc.
Usage: RAPIVAB treats acute uncomplicated influenza in patients 6 months and older who have been symptomatic for no more than 2 days. Primarily studied in influenza A; limited data on influenza B. Not established for serious influenza requiring hospitalization.